LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY
dc.authorid | Cinier, Goksel / 0000-0001-5064-1816 | |
dc.authorid | Mert, Kadir Ugur / 0000-0002-1331-5365 | |
dc.authorwosid | Cinier, Goksel / Y-1715-2019 | |
dc.authorwosid | Mert, Gurbet Ozge / AAH-7736-2019 | |
dc.authorwosid | Mert, Kadir Ugur / D-6727-2016 | |
dc.authorwosid | Bekar, Lutfu / A-6945-2019 | |
dc.contributor.author | Basaran, O. | |
dc.contributor.author | Dogan, V. | |
dc.contributor.author | Mert, G. O. | |
dc.contributor.author | Mert, K. U. | |
dc.contributor.author | Ozlek, B. | |
dc.contributor.author | Celik, O. | |
dc.contributor.author | Kayikciolu, M. | |
dc.date.accessioned | 2021-11-01T15:02:59Z | |
dc.date.available | 2021-11-01T15:02:59Z | |
dc.date.issued | 2019 | |
dc.department | [Belirlenecek] | |
dc.description | 87th Congress of the European-Atherosclerosis-Society (EAS) -- MAY 26-29, 2019 -- Maastricht, NETHERLANDS | |
dc.description.abstract | [Abstract Not Available] | |
dc.description.sponsorship | European Atherosclerosis Soc | en_US |
dc.identifier.doi | 10.1016/j.atherosclerosis.2019.06.618 | |
dc.identifier.endpage | E203 | en_US |
dc.identifier.issn | 0021-9150 | |
dc.identifier.issn | 1879-1484 | |
dc.identifier.startpage | E203 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.atherosclerosis.2019.06.618 | |
dc.identifier.uri | https://hdl.handle.net/11491/6902 | |
dc.identifier.volume | 287 | en_US |
dc.identifier.wos | WOS:000482110800616 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.institutionauthor | [Belirlenecek] | |
dc.language.iso | en | |
dc.publisher | Elsevier Ireland Ltd | |
dc.relation.ispartof | Atherosclerosis | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | [No Keywords] | en_US |
dc.title | LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY | |
dc.type | Conference Object |